Patient Death Triggers FDA Partial Clinical Hold on MacroGenics' LINNET Trial for Gynecologic Cancers on February 26, 2026 Carduelis cannabina Clinical Trials lorigerlimab MacroGenics Malignant Female Reproductive System Neoplasm Partial patient death United States Food and Drug Administration +
Patient Dies from Thrombotic Stroke in Pfizer's Hympavzi Hemophilia Trial After Minor Surgery on December 24, 2025 Clinical Trials Hemophilia A HYMPAVZI marstacimab patient death Pfizer Thrombotic Stroke +
Patient Hospitalized After Receiving Intellia's CRISPR Therapy Dies, Prompting FDA Hold on Trials on November 07, 2025 Amyloidosis Clinical Trials Comorbidity CRISPR therapy Intellia Liver nex-z nexiguran ziclumeran patient death Phase III MAGNITUDE trial Toxicity aspects TTR wt Allele United States Food and Drug Administration +